ConductScience.org, home

Paper42638743

The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B.

Zhang Y and 4 others. Front Immunol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B. Papers, record 42638743. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42638743

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B.
PubMed
Journal
Front Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYuzhen
2Yang SShuqi
3Lin YYanyan
4Qiu YYanyan
5Yu XXueping

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptors, ImmunologicMajor topic
Hepatitis B, ChronicMajor topic
Receptors, Tumor Necrosis Factor, Member 14Major topic
Hepatitis B virusMajor topic
Humans
T-Cell Exhaustion
Signal Transduction
Animals
Programmed Cell Death 1 Receptor

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130770415Soluble Fc-Disabled Herpes Virus Entry Mediator Augments Activation and Cytotoxicity of NK Cells by Promoting Cross-Talk between NK Cells and Monocytes.J Immunol2019https://conductscience.org/library/papers/30770415PubMed
238976867A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative.Hepatology2025https://conductscience.org/library/papers/38976867PubMed
340559604Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue.Pathogens2025https://conductscience.org/library/papers/40559604PubMed
440988451Current status of management of immune-related adverse events and practical needs for oncologist education.Cancer Biol Med2025https://conductscience.org/library/papers/40988451PubMed
533917094BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.Cancers (Basel)2021https://conductscience.org/library/papers/33917094PubMed
631204070The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.Immunity2019https://conductscience.org/library/papers/31204070PubMed
727793593Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.Immunity2016https://conductscience.org/library/papers/27793593PubMed
832437509PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.J Cell Biol2020https://conductscience.org/library/papers/32437509PubMed
922658127Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.N Engl J Med2012https://conductscience.org/library/papers/22658127PubMed
1030622109Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load.Gut2019https://conductscience.org/library/papers/30622109PubMed
1141179730Hepatitis B functional cure: Current and future perspective.World J Hepatol2025https://conductscience.org/library/papers/41179730PubMed
1229853659Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade.Oncologist2018https://conductscience.org/library/papers/29853659PubMed
1333332777The BTLA and PD-1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells.Immun Inflamm Dis2021https://conductscience.org/library/papers/33332777PubMed
1420038811BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.J Clin Invest2010https://conductscience.org/library/papers/20038811PubMed
1530580250Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.Gut2019https://conductscience.org/library/papers/30580250PubMed
1634734802Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.Elife2021https://conductscience.org/library/papers/34734802PubMed
1734172516Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.J Immunother Cancer2021https://conductscience.org/library/papers/34172516PubMed
1835312715Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis.PLoS One2022https://conductscience.org/library/papers/35312715PubMed
1932206094Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations.Ther Adv Musculoskelet Dis2020https://conductscience.org/library/papers/32206094PubMed
2025101233Immunosuppression in Patients with Chronic Hepatitis B.Curr Hepatol Rep2014https://conductscience.org/library/papers/25101233PubMed

See all 46 referencesDownload CSV of references

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42638743

GET https://conductscience.org/api/papers/v1/42638743/references?page=2